// App-Quantinova.ai

20675 : Longest Available Follow-Up of Drug-Eluting Stents in Real World Practice - Outcomes up to 12 Years From the DESIRE Registry

Researchers

Presenter

  • Amanda Sousa

Principal Investigators

  • Adriana Moreira

  • J. Eduardo Sousa

  • J. Ribamar Costa Jr

  • Galo Maldonado

  • Manuel Cano

  • Carlos Gordilho

  • Lucas P Damiani

  • Cantidio Campos Neto

  • Ricardo Pavanello

Medical Centers

  • Hospital do Coracao - Associacao do Sanatorio Sirio, Sao Paulo, Brazil

Locations

  • Brazil

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Peripheral artery disease

  • Acute Coronary Syndromes

  • Myocardial infarction

  • Renal insufficiency

  • Dyslipidemia

  • Venous thrombosis

  • Diabetes

Biomarkers

  • N/A

Drug/Treatment

  • Roxithromycin

Outcome

  • N/A

Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved